Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CCR8 (CD198) Mouse anti-Human , PE-CF594, Clone: 433H, BD Biosciences™

Mouse Monoclonal Antibody

$225.00 - $438.00

Specifications

Antigen CCR8 (CD198)
Clone 433H
Applications Flow Cytometry
Classification Monoclonal
Conjugate PE-CF594
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
BDB566889
View Documents
BD Biosciences
566889
25 Tests
Each for $225.00
Only null left
Add to Cart
 
BDB566888
View Documents
BD Biosciences
566888
100 Tests
Each for $438.00
Only null left
Add to Cart
 
Description

Description

CCR8 (CD198) Monoclonal antibody specifically detects CCR8 (CD198) in Human samples. It is validated for Flow Cytometry
Specifications

Specifications

CCR8 (CD198)
Flow Cytometry
PE-CF594
RUO
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Human CCR8 Transfected Cell Line
Primary
433H
Monoclonal
Mouse
Human
CCR8; CKR-L1; CKRL1; CMKBR8; CMKBRL2; CY6; GPR-CY6; GPRCY6; MGC129966; MGC1
IgG2a κ
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon™ PE-CF594 under optimum conditions, and unconjugated antibody and free PE-CF594 were removed.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.